AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Would-be competitors eye Amgen's EPO market lock-up.
April 1, 2002... You might not expect onlookers to be especially sanguine about competitors against erythropoietin king Amgen Inc., which continues to reap revenues galore from its blood-boosting blockbuster drug. Last week, though, two companies with EPO...
Money raised by Biotech in 2002 vs. 2001.
April 1, 2002...
Money Raised By Biotech
In 2002 Vs. 2001
Jan. 1 - March 28, Jan. 1 - March 29,
2002; $5,019.87M 2001; $2,316M
Public/Other (*) 3,346 361
Private Biotechs ...
10 biggest U.S. gainers & losers for the week.
April 1, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
Dendrcon 23.31 Cerus Corp. 3.52
Esperion 20.59 Martek Bio 2.27
ViroLogic 17.05 Ncose Technol 2.05...
Biotechnology company deals with other Biotechnology companies: Collaborations, greements, equity participation, Dec. 18, 2001 -- March 25, 2002.
April 1, 2002...
Biotechnology Company Deals With Other Biotechnology Companies:
Collaborations, Agreements, Equity Participation, Dec. 18, 2001 -- March
25, 2002 (#)
Company (*) Company (*) Type/Product Area
(Country, ...
Manufacturing, marketing and distribution agreements between Biotech companies: Dec. 6, 2001 - March 25, 2002.
April 1, 2002...
Manufacturing, Marketing And Distribution Agreements Between Biotech
Companies: Dec. 6, 2001 - March 25, 2002 (#)
Biotech Co. (*) Biotech Co. (*) Product
(Country/ (Country/
Symbol) Symbol)
Avid ...
Biotech -- Biotech collaborations modified and terminated agreements, Jan. 1 -- March 25, 2002.
April 1, 2002...
Biotech -- Biotech Collaborations Modified And Terminated Agreements,
Jan. 1 -- March 25, 2002 (#)
I. MODIFIED AGREEMENTS
Biotech Co. (*) Biotech Co. (*) Change from original
(Country/ (Country/ agreement...
BioWorld stock report for public biotechnology companies.
April 1, 2002...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close %Change
3/22 3/29 WK YTD
3D Pharma DDDP 6.95 6.83 ...
Alkermes' acquisition of reliant brings 'one-step transformation'.
April 8, 2002... You don't hear the term "overnight sensation" much in biotechnology (in fact, you don't hear it much at all. now that variety show host Ed Sullivan Is gone), but the tag seems just right for Alkermes Inc. -- even if those who know him might...
10 biggest U.S. Gainers & Losers for the week.
April 8, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
GalaGen 116.67 Ccrus Corp. 2.30
Viragen 38.27 Epix Medical 2.05
Synsorb Biotech 36.84 Embrex ...
Money raised by biotech in 2002 vs. 2001.
April 8, 2002...
Money Raised by Biotech In 2002 Vs. 2001
Jan. 1 -- April Jan. 1 -- April
4, 2002: 5, 2001:
$5,039.58M $2,560M
Public/Other (*) 3,350 361...
Public financing of biotechnology: March 2002.
April 8, 2002... I. COMMENCED TRADING IN MARCH
INITIAL OFFERINGS
There were no initial public offerings conducted in March.
Total: $0M
Number of IPOs in March: 0
Average value at March IPOs: $OM
Number of IPOS in 2002: 1
Total...
Other financings of public Biotechnology Companies: March 2002.
April 8, 2002...
Other Financings Of Public Biotechnology Companies: March 2002
TOTAL: $172.15M
Company Type of Number Of Amount
(Symbol)# Financing Shares, Units Raised
...
Venture Capital and corporate investments in Biotechnology Companies: March 2002.
April 8, 2002...
Venture Capital And Corporate Investments In Biotechnology Companies:
March 2002
I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES
Company Location Date
Aegera Montreal ...
Money raised by Biotech in 2002: January-March.
April 8, 2002...
Money Raised By Biotech In 2002: January-March
Type of
financing I($M) F($M) M($M) Total($M)
Public offerings 75.1 345.8 281.9 702.8
Private blotechs 341.0 241.6 247.3 829.9
Public/other ...
Bioworld stock report for public Biotechnology Companies.
April 8, 2002...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close % Change
3/29 4/5 WK YTD
3D Pharma DDDP 6.83 6.76 ...
Biotechnology's cancer focus bringing better drugs, no cure.
April 15, 2002... Cancer,
Few words strike fear into the heart more than cancer. The disease kills with such proficiency that it is not particularly shocking when someone develops cancer, instead being more significant when cancer is actually defeated....
10 biggest U.S. gainers for the week.
April 15, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(BY Percent)
Iata Pharma 86.15
Avant Immumo 36.78
Lynx Thcrapcutica 30.34
Cygnus 25.37
Dyax 19.68
Onyx Pharma 19.32
Rigel ...
10 biggest U.S. losers for the week.
April 15, 2002...
10 BIGGEST U.S. LOSERS FOR THE WEEK
(By Percent)
Demegen -46.15
Cel-Sci -34.09
Avax Technol -33.33
GalaGen -23.08
Viragen -21.43
Tularik -19.68
Gliatech -19.57
Genz Mol...
Correction.
April 15, 2002... Figures from a financing of a non-biotech company were mistakenly included in the April 8, 2002, Bio World Financial Watch issue. On page 4, the correct figure for the total of March follow-on offerings is $156.9 million. The number of...
Clinical trial update: March 2002.
April 15, 2002...
Clinical Trial Update: March 2002
CANCER
Company (*) Product Description
(Symbol)
AltaRex Corp. OvaRex Oregovomab; a fully
(Canada; TSE:AXO) foreign monoclonal
...
Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: March 2002.
April 15, 2002...
Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And
Approvals: March 2002
CANCER
Company (*)
(Symbol) Product Description
Ark EG009 Gene therapy product...
FDA submissions, approvals and other actions: March 2002.
April 15, 2002...
FDA Submissions, Approvals And Other Actions: March 2002
CANCER
Company (*)
(Symbol) Product Description
Celgene Corp. Thalomid Thalidomide;
(CELG) modulates level of
...
BioWorld stock report for Public Biotechnology Companies.
April 15, 2002...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close %Change
4/5 4/12 WK YTD
3D Pharma DDDP 6.76 6.41 ...
London stock exchange.
April 15, 2002...
LONDON STOCK EXCHANGE
Company Symbol 4/5 4/12 % WK % YTD Volume
Acambis ACM 323 320 -0.93 -8.70 3454
Antisoma ASM 20.5 20.5 0.00 -42.25 2083
British Biotach BBG ...
Toronto stock exchange.
April 15, 2002...
TORONTO STOCK EXCHANGE
Company Symbol 4/5 4/12 % WK % YTD Volume
Adherex AHX 0.47 0.54 14.89 28.57 563
Angiotech Pharma ANP 72 71.09 -1.26 -20.12 195
Anormed ...
MS data war heats up: Is Avonex stronahold secure?
April 22, 2002... Multiple sclerosis -- as many of those afflicted know all too well -- is characterized in extreme forms by tissue-hardening paralysis, during Its often-painful march through the brains and spinal cords of victims. But the competitive arena for...
10 biggest U.S. gainers & losers for the week.
April 22, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
Adolor 54.31 Trimeris 11.05
Avax Technol 45.00 Adolor 5.35
Ccl-Sci 37.93 Vertex Pharma 3.46
British...
Biotech -- Big Pharma Collaborations: New Agreements, Feb. 20 -- April 17, 2002.
April 22, 2002...
Biotech -- Big Pharma Collaborations: New Agreements, Feb. 20 -- April
17, 2002 (#)
Biotech Co. (*) Pharma Co.
(Country; (Country)
Symbol)
3M Drug Novartis Pharma AG
Delivery ...
Manufacturing, Marketing and Distribution Agreements Between Biotech and Pharmaceutical Companies: Feb. 20 -- April 17, 2002.
April 22, 2002...
Manufacturing, Marketing And Distribution Agreements Between Biotech And
Pharmaceutical Companies: Feb. 20 -- April 17, 2002 (#)
Biotech Co. (*)
(Country; Pharma Co.
Symbol) (Country) Product
...
Biotech -- Big Pharma Collaborations: Modified and Terminated Agreements, Feb. 20 -- April 17, 2002.
April 22, 2002...
Biotech -- Big Pharma Collaborations: Modified And Terminated
Agreements, Feb. 20 -- April 17, 2002 (#)
I. MODIFIED AGREEMENTS
Biotech Co. (*) Pharma Co.
(Country: Symbol) (Country)
Applied Eli Lilly and...
BioWorld Stock Report for Public Biotechnology Companies.
April 22, 2002...
BioWorld Stock Report For Public Biotechnology Companies
Company Symbol Close Close %Change
4/5 4/12 WK YTD
3D Pharma DDDP 6.41 6.81 ...
London Stock Exchange.
April 22, 2002...
LONDON STOCK EXCHANGE
Company Symbol 4/5 4/12 %WK %YTD Volume
Acambis ACM 320 313 -2.19 -10.70 2869
Antisoma ASM 20.5 20.5 0.00 42.25 523
British Biotech BBG...
Toronto Stock Exchange.
April 22, 2002...
TORONTO STOCK EXCHANGE
Company Symbol 4/5 4/12 %WK %YTD Volume
Adherex AHX 0.54 0.52 -3.70 23.81 166
Angiotech Pharma ANP 71.09 73.75 3.74 -17.13 113
Anormed ...
Money Raised by Biotech in 2002 Vs. 2001.
April 22, 2002...
Money Raised By Biotech In 2002 Vs. 2001
Jan. 1 -- April 18, Jan. 1 -- April 19,
2002: $5,485.22M 2001: $2,766M
Public/Other (*) 3,538 421
Private Biotechs ...
ESO accounting changes could hurt biotech hiring, bottom lines.
April 29, 2002... As if implications of the Enron Corp. situation hadn't already messed things up enough for biotechnology (and Just about every other sector that uses balance sheets and ledgers), another spawn of the scandal has reared its head for industry...
10 biggest U.S. gainers for the Week.
April 29, 2002...
10 BIGGEST U.S. GAINERS FOR THE WEEK
(By Percent) (By Dollars)
Select Therapeu 78.57 Immucor 2.50
Interleukin 42.00 Tripos 2.34
Immune Rcsp 36.96 Cholestech 1.60...
Money raised by biotech in 2002 vs. 2001.
April 29, 2002...
Money Raised By Biotech in 2002 vs. 2001
Millions
Jan. 1 - April 25, Jan. 1 - April 26,
2000: $6,343.24M 2000: $2,884M
Public/Other (*) 4,242 ...
Correction.
April 29, 2002... The stock charts on pages 14 and 15 in the April 22, 2002, issue of BioWorld Financial Watch had the wrong headers. They should have said 4/12 and 4/19 instead of 4/5 and 4/12. The stock closing prices were correct.
Editor's note: The...
Biotech Mergers and Acquisitions: Feb. 28 - April 25, 2002.
April 29, 2002...
Biotech Mergers and Acquisitions: Feb. 28 - April 25, 2002 (#)
I. COMPLETED MERGERS AND ACQUISITIONS
Acquired By Or Merged Date
Company Acquired (*) With (*) Announced...
BioWorld stock report for public biotechnology companies.
April 29, 2002...
BioWorld Stock Report For Public Biotechnology Companies
% Change
Company Symbol Close Close
4/19 4/26 WK YTD
...
London stock exchange.
April 29, 2002...
LONDON STOCK EXCHANGE
Company Symbol 4/19 4/26 %WK %YTD Volume
Acambis ACM 313 295 -5.75 -15,83 3562
Antiaoma ASM 20.5 22 7.32 -38.03 5429
British Biotech BBG...
Toronto stock exchange.
April 29, 2002...
TORONTO STOCK EXCHANGE
Company Symbol 4/19 4/26 %WK %YTD Volume
Adherex AHX 0.52 0.56 7.69 33.33 514
Angiotech Pharma ANP 73.75 62.1 -15.80 -30.22 366
Anormed ...